Artificial intelligence is revolutionising genomics by speeding up genetic analysis, enabling precision medicine, improving drug discovery, and supporting large-scale health research. AI is helping deliver earlier diagnoses, more effective treatments, and better healthcare outcomes worldwide.

Researchers at the University of Cambridge and DIOSynVax have developed an AI-powered vaccine platform designed to protect against entire virus families. Early trial results show strong safety and immune responses, raising hopes for broader disease prevention and pandemic preparedness.